t(11;14) patients are characterized, in comparison to SR patients, by lower incidences of IgA, and of plasmacytomas, but a higher probability of having oligosecretory and non-secretory disease, higher PC bone marrow infiltration and levels of serum calcium. The gene discussed is CD79A; the disease is plasmacytoma.